The present invention is directed to the use of human BC200 RNA in both the diagnosis and prognosis of carcinomas to determine the presence of a carcinoma and tumor grade, and also to predict the likelihood that a carcinoma will progress to an invasive carcinoma.
CROSS REFERENCE TO RELATED APPLICATIONS
This application is a national phase application of PCT/US03/05502, having an international filing date of Feb. 21, 2003, which claims priority to U.S. Provisional Application No. 60/359,156, filed Feb. 22, 2002, the contents of which are incorporated by reference herein.
